PSD Exam 1

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/99

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

100 Terms

1
New cards

Community Pharmacy Workflow Steps

  1. Pharmacy receives → 2. Data Entry → 3. Pre-check → 4. Dispensing → 5. Final check → 6. Patient receives

2
New cards

Pharmacy receives the prescription

Includes written Rx in person, fax, electronic/e-prescription, telephone from prescriber's office, voice mail, or transfer Rx from another pharmacy.

3
New cards

Data Entry

Involves patient info, interpreting & assessing prescription data, and entering information into the computer.

4
New cards

Pre-check

Completed by a pharmacist at some pharmacy locations to verify data entry and check for safety & appropriateness before dispensing.

5
New cards

Dispensing

Involves printing the Rx label, locating & selecting medication, safety scan to verify meds, and counting, packaging & labeling the meds.

6
New cards

Final check

Verification completed by pharmacist to check for appropriateness/safety and assess for accuracy of medication prescribed.

7
New cards

Patient receives the prescription

Any pharmacy staff member may release Rx to patient and must verify the correct patient is receiving the prescription.

8
New cards

Required components of a written outpatient prescription

Date, prescriber info, patient info, medication info, DAW rules, and manual signature for paper Rx.

9
New cards

Controlled substances requirements

DEA# required and quantity to dispense must be written numerically and alphabetically.

10
New cards

Required components of an outpatient prescription label

Pharmacy info, full name of patient, name of prescriber, Rx# / prescription serial number, date dispensed, drug name and strength, drug distributor/manufacturer, quantity dispensed, and Rx directions.

11
New cards

DEA# validity check

DEA# consists of 2 letters followed by 7 numbers; the first letter indicates the type of practitioner and the second letter is the first initial of the prescriber's last name.

12
New cards

Initial filling timeframe for prescriptions

Noncontrolled and C-V controlled drugs = 6 months; Opioid analgesics (CII-CIV) = 14 days from the date prescription was written.

13
New cards

Refill timeframe for prescriptions

C-II controlled drugs = ZERO refills; C-III and C-IV = 6 months; Noncontrolled and C-V = 1 year from the date prescription was written.

14
New cards

Schedule I drugs

Includes heroin, LSD, ecstasy, and marijuana.

15
New cards

Schedule II drugs

Includes oxycodone, hydrocodone, morphine, methylphenidate, and dextroamphetamine.

16
New cards

Schedule III drugs

Includes testosterone and certain analgesics with codeine (e.g., Tylenol with codeine).

17
New cards

Schedule IV drugs

Includes lorazepam, alprazolam, tramadol, and zolpidem.

18
New cards

Schedule V drugs

Includes pregabalin and certain cough syrups with codeine.

19
New cards

PPCP steps

Collect → Assess → Plan → Implement → Follow-up.

20
New cards

PPCP purpose

Used for patient evaluation and problem solving through a patient-centered approach.

21
New cards

Collect in PPCP

Pharmacists collect necessary subjective & objective information about the patient.

22
New cards

Assess in PPCP

Pharmacist assesses collected info and analyzes clinical effects of therapy in context of overall health goals.

23
New cards

Plan in PPCP

Pharmacist develops an individualized patient-centered care plan in collaboration with other healthcare professionals.

24
New cards

Implement in PPCP

Pharmacist implements the care plan in collaboration with other healthcare professionals.

25
New cards

Follow-up in PPCP

Pharmacist monitors and evaluates the effectiveness of the care plan and modifies it as needed.

26
New cards

Importance of documenting interventions

Essential for tracking patient care and ensuring continuity and quality of care.

27
New cards

PPCP

Framework for pharmacists' patient care activities.

28
New cards

SOAP Note

Structured documentation of patient encounters.

29
New cards

Subjective Data

Information from patient's personal experiences.

30
New cards

Objective Data

Information obtained through direct measurement.

31
New cards

Assessment

Identifying and prioritizing patient problems.

32
New cards

Plan

Recommendations for treatment and follow-up.

33
New cards

Follow-up

Monitoring therapy effectiveness and safety.

34
New cards

Drug-Related Problem (DRP)

Issues affecting optimal patient drug therapy outcomes.

35
New cards

BMI Calculation

Weight in pounds divided by height squared.

36
New cards

IBW Calculation

Ideal weight based on height and gender.

37
New cards

CrCl Calculation

Estimates kidney function using age and weight.

38
New cards

Adverse Drug Reaction

Harmful response to medication.

39
New cards

Drug Interaction

Effects of one drug altered by another.

40
New cards

Pharmacokinetics

Study of drug absorption, distribution, metabolism, excretion.

41
New cards

Tertiary Literature

Summarized information from original research.

42
New cards

Secondary Literature

Indexes and abstracts of primary research.

43
New cards

Primary Literature

Original research articles and case reports.

44
New cards

Drug Monograph

Comprehensive summary of a drug's information.

45
New cards

Boxed Warning

Severe safety information about a drug.

46
New cards

REMS

Risk Evaluation and Mitigation Strategies for drugs.

47
New cards

Pharmacology

Mechanism of action and drug effects.

48
New cards

Indications and Use

Approved uses of a medication.

49
New cards

Dosing Adjustments

Modifications based on patient-specific factors.

50
New cards

Overdose Toxicology

Information on overdose effects and treatment.

51
New cards

Background Information

Patient details needed for drug information requests.

52
New cards

Drug Identification

Determining the identity of a medication.

53
New cards

Product Availability

Information on whether a drug is in stock.

54
New cards

Poisoning

Toxic effects from harmful substances.

55
New cards

Literature Hierarchy

Ranking of information sources by reliability.

56
New cards

Effective Drug Information Skills

Essential skills for pharmacists in patient care.

57
New cards

Special populations

Groups needing dose adjustments due to specific conditions.

58
New cards

Administration

Guidelines on how to take a drug properly.

59
New cards

Overdose

Excessive drug intake leading to harmful effects.

60
New cards

Contraindications

Conditions under which a drug should not be used.

61
New cards

Warnings and precautions

Advisories for patients requiring special monitoring.

62
New cards

Pregnancy considerations

Drug safety information for pregnant individuals.

63
New cards

Lactation considerations

Drug safety information for breastfeeding individuals.

64
New cards

Adverse reactions

Negative effects categorized by organ systems.

65
New cards

Drug Interactions

Effects when two or more drugs are combined.

66
New cards

Monitoring parameters

Tests needed to ensure drug efficacy and safety.

67
New cards

Dosage forms

Different forms and strengths of drug preparations.

68
New cards

Stability/Storage

Conditions for proper drug storage and handling.

69
New cards

Patient education

Information provided to patients about their medications.

70
New cards

REMS Information

Safety program ensuring medication benefits outweigh risks.

71
New cards

DailyMed

Online database for FDA-approved drug information.

72
New cards

Facts and Comparisons

Resource for comparing drug products and active ingredients.

73
New cards

Lexi-Drugs

Quick reference database for drug information.

74
New cards

Martindale

International drug reference with detailed monographs.

75
New cards

AHFS-DI

Comprehensive drug monographs for healthcare professionals.

76
New cards

Excipient

Inactive substance in drug formulations for stability.

77
New cards

NDC

Unique identifier for human drug products in the US.

78
New cards

Proprietary name

Brand name assigned to a specific drug product.

79
New cards

Nonproprietary name

Generic name or active ingredient of a drug.

80
New cards

Pharmaceutical equivalence

Same active ingredient and dosage form in drugs.

81
New cards

Therapeutic equivalence

Drugs with same clinical effect and safety profile.

82
New cards

ASHP Drug Shortage Database

Resource for current drug shortage information.

83
New cards

FDA Orange Book

Resource for FDA approval and market availability.

84
New cards

Discontinued Drug Products

Information found in FDA Orange Book and Micromedex.

85
New cards

Physical Characteristics

Identifying drugs via appearance and inscription codes.

86
New cards

Generic Drug Name

Used to find manufacturer and foreign brand names.

87
New cards

Inactive Ingredients

Excipients like sugar and dyes listed in DailyMed.

88
New cards

Prescription Status

Determines if a drug is Rx-only or OTC.

89
New cards

Controlled Substance

Drug classification found in DailyMed and Facts & Comparisons.

90
New cards

Therapeutic Equivalence Code

Indicates FDA's AB rating for drug equivalence.

91
New cards

Pharmaceutical Equivalence

Drugs must share active ingredient, form, route, strength.

92
New cards

Orphan Drug

For rare diseases; info found in FDA database.

93
New cards

AWP

Average Wholesale Price; cost reference in Micromedex.

94
New cards

Prescription Transfer Requirements

Includes pharmacy details and prescription duplicates.

95
New cards

Rx# / Serial Number

Unique identifier for each prescription transfer.

96
New cards

Patient Information

Includes full name, address, and date of birth.

97
New cards

Prescriber Information

Includes prescriber's full name, address, and DEA#.

98
New cards

Transfer Prescription Notation

Word 'transfer' must appear on transferred Rx.

99
New cards

Refill Communication Format

Number of refills communicated in 1+X format.

100
New cards

Controlled Substance Transfer Law

Only refills for Schedule III-V can be transferred.